alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.
Thall
A D
AD
Department of Pathology, University of Michigan, Ann Arbor, USA.
Murphy
H S
HS
Lowe
J B
JB
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis*; D000917:Antibody Formation; D002240:Carbohydrate Sequence; D002478:Cells, Cultured; D003165:Complement System Proteins; D003602:Cytotoxicity, Immunologic; D004730:Endothelium, Vascular / Q000276:immunology; D005260:Female; D005690:Galactose; D005697:Galactosides / Q000276:immunology*; D005700:Galactosyltransferases / Q000172:deficiency* / Q000235:genetics; D006801:Humans; D008297:Male; D008322:Mammals; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000276:immunology*; D009865:Oocytes / Q000502:physiology; D013084:Sperm-Ovum Interactions / Q000276:immunology; D013090:Spermatocytes / Q000502:physiology; D013552:Swine
D000910:Antibodies, Heterophile; D005697:Galactosides; D009844:Oligosaccharides; D003165:Complement System Proteins; D005700:Galactosyltransferases; C037959:beta-D-galactosyl-N-acetylglucosaminylglycopeptide alpha-1,3-galactosyltransferase; D005690:Galactose